Here is the actual text from the press release dated February 10, 2009:
For the full press release:
http://cordblood.net/pdf/cbrbusiness_release_final.pdf
This is truly an exciting time for stem cells and the hearing loss cure at last.
Increasingly, researchers are using an individual’s own stem cells to explore new regenerative therapies because autologous stem cell therapy avoids medical complications and safety concerns that may develop with stem cells donated or created from another source. The key to initiating new trials is identifying children who have a specific condition and who have access to their own newborn stem cells.
In a city whose population equals the number of cord blood units stored at CBR, statistics calculated from Center of Disease Control (CDC) data would predict that every 1 in 50 children by age 6 will develop or experience a condition that has no cure today and is currently being researched for treatment with newborn stem cells. This includes traumatic brain injury, cerebral palsy, stroke, type 1 diabetes, heart disorders and hearing loss.
Cord Blood Registry also announced today that it is in discussions with three leading medical institutions to launch a clinical study that will evaluate the use of a child’s own newborn stem cells to treat hearing loss caused by an accident or severe illness.
The research will be facilitated and coordinated by The CBR Center for degenerative Medicine, which was established by Cord Blood Registry as a scientific research collaborative with leading medical research institutions from around the country. The company estimates that more than 600 children already banked with CBR may have some form of severe hearing loss. The CBR Center for Regenerative Medicine is currently screening potential candidates for this study.
For the full press release:
http://cordblood.net/pdf/cbrbusiness_release_final.pdf
This is truly an exciting time for stem cells and the hearing loss cure at last.